Logo image of 0B2.DE

BAWAG GROUP AG (0B2.DE) Stock Fundamental Analysis

FRA:0B2 - Deutsche Boerse Ag - AT0000BAWAG2 - Common Stock - Currency: EUR

110  +0.5 (+0.46%)

Fundamental Rating

4

Overall 0B2 gets a fundamental rating of 4 out of 10. We evaluated 0B2 against 89 industry peers in the Banks industry. 0B2 has a medium profitability rating, but doesn't score so well on its financial health evaluation. 0B2 is not valued too expensively and it also shows a decent growth rate. Finally 0B2 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

0B2 had positive earnings in the past year.
In the past year 0B2 had a positive cash flow from operations.
In the past 5 years 0B2 has always been profitable.
0B2 had a positive operating cash flow in 4 of the past 5 years.
0B2.DE Yearly Net Income VS EBIT VS OCF VS FCF0B2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

0B2's Return On Assets of 1.03% is fine compared to the rest of the industry. 0B2 outperforms 70.79% of its industry peers.
Looking at the Return On Equity, with a value of 15.59%, 0B2 belongs to the top of the industry, outperforming 83.15% of the companies in the same industry.
Industry RankSector Rank
ROA 1.03%
ROE 15.59%
ROIC N/A
ROA(3y)0.91%
ROA(5y)0.81%
ROE(3y)12.92%
ROE(5y)11.08%
ROIC(3y)N/A
ROIC(5y)N/A
0B2.DE Yearly ROA, ROE, ROIC0B2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

0B2 has a Profit Margin of 37.12%. This is amongst the best in the industry. 0B2 outperforms 88.76% of its industry peers.
In the last couple of years the Profit Margin of 0B2 has grown nicely.
The Operating Margin and Gross Margin are not available for 0B2 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 37.12%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y9.26%
PM growth 5Y4.48%
GM growth 3YN/A
GM growth 5YN/A
0B2.DE Yearly Profit, Operating, Gross Margins0B2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

0B2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 0B2 has about the same amount of shares outstanding.
0B2 has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 0B2 has been reduced compared to a year ago.
0B2.DE Yearly Shares Outstanding0B2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
0B2.DE Yearly Total Debt VS Total Assets0B2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

0B2 has a debt to FCF ratio of 14.48. This is a negative value and a sign of low solvency as 0B2 would need 14.48 years to pay back of all of its debts.
0B2 has a Debt to FCF ratio of 14.48. This is amongst the best in the industry. 0B2 outperforms 85.39% of its industry peers.
A Debt/Equity ratio of 3.65 is on the high side and indicates that 0B2 has dependencies on debt financing.
0B2's Debt to Equity ratio of 3.65 is on the low side compared to the rest of the industry. 0B2 is outperformed by 78.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.65
Debt/FCF 14.48
Altman-Z N/A
ROIC/WACCN/A
WACC8.01%
0B2.DE Yearly LT Debt VS Equity VS FCF0B2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
0B2.DE Yearly Current Assets VS Current Liabilites0B2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

0B2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.40%, which is quite good.
The Earnings Per Share has been growing by 15.63% on average over the past years. This is quite good.
The Revenue has grown by 11.07% in the past year. This is quite good.
The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)15.4%
EPS 3Y21.26%
EPS 5Y15.63%
EPS Q2Q%20.38%
Revenue 1Y (TTM)11.07%
Revenue growth 3Y7.51%
Revenue growth 5Y5.95%
Sales Q2Q%36.15%

3.2 Future

0B2 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.12% yearly.
The Revenue is expected to grow by 3.94% on average over the next years.
EPS Next Y13.97%
EPS Next 2Y14.24%
EPS Next 3Y14.4%
EPS Next 5Y4.12%
Revenue Next Year36.67%
Revenue Next 2Y20.09%
Revenue Next 3Y14.96%
Revenue Next 5Y3.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
0B2.DE Yearly Revenue VS Estimates0B2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
0B2.DE Yearly EPS VS Estimates0B2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.96, the valuation of 0B2 can be described as very reasonable.
68.54% of the companies in the same industry are cheaper than 0B2, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 0B2 to the average of the S&P500 Index (27.30), we can say 0B2 is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.77, the valuation of 0B2 can be described as very reasonable.
Based on the Price/Forward Earnings ratio, 0B2 is valued a bit cheaper than the industry average as 74.16% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 0B2 to the average of the S&P500 Index (21.76), we can say 0B2 is valued rather cheaply.
Industry RankSector Rank
PE 10.96
Fwd PE 8.77
0B2.DE Price Earnings VS Forward Price Earnings0B2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

0B2's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 0B2 is cheaper than 82.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.25
EV/EBITDA N/A
0B2.DE Per share data0B2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
0B2's earnings are expected to grow with 14.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.78
PEG (5Y)0.7
EPS Next 2Y14.24%
EPS Next 3Y14.4%

7

5. Dividend

5.1 Amount

0B2 has a Yearly Dividend Yield of 7.76%, which is a nice return.
Compared to an average industry Dividend Yield of 5.20, 0B2 pays a better dividend. On top of this 0B2 pays more dividend than 93.26% of the companies listed in the same industry.
0B2's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 7.76%

5.2 History

On average, the dividend of 0B2 grows each year by 16.72%, which is quite nice.
Dividend Growth(5Y)16.72%
Div Incr Years3
Div Non Decr Years3
0B2.DE Yearly Dividends per share0B2.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

53.25% of the earnings are spent on dividend by 0B2. This is a bit on the high side, but may be sustainable.
0B2's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP53.25%
EPS Next 2Y14.24%
EPS Next 3Y14.4%
0B2.DE Yearly Income VS Free CF VS Dividend0B2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B
0B2.DE Dividend Payout.0B2.DE Dividend Payout, showing the Payout Ratio.0B2.DE Dividend Payout.PayoutRetained Earnings

BAWAG GROUP AG

FRA:0B2 (7/11/2025, 7:00:00 PM)

110

+0.5 (+0.46%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners52.24%
Inst Owner ChangeN/A
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap8.65B
Analysts83.16
Price Target120.79 (9.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.76%
Yearly Dividend5.01
Dividend Growth(5Y)16.72%
DP53.25%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.66%
Min EPS beat(2)2.32%
Max EPS beat(2)19%
EPS beat(4)4
Avg EPS beat(4)5.56%
Min EPS beat(4)0.02%
Max EPS beat(4)19%
EPS beat(8)6
Avg EPS beat(8)3%
EPS beat(12)8
Avg EPS beat(12)1.52%
EPS beat(16)12
Avg EPS beat(16)4.27%
Revenue beat(2)0
Avg Revenue beat(2)-3.12%
Min Revenue beat(2)-3.68%
Max Revenue beat(2)-2.55%
Revenue beat(4)0
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-3.68%
Max Revenue beat(4)-1.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.91%
PT rev (3m)4.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.38%
Valuation
Industry RankSector Rank
PE 10.96
Fwd PE 8.77
P/S 4.35
P/FCF 7.25
P/OCF 6.95
P/B 1.83
P/tB 2.06
EV/EBITDA N/A
EPS(TTM)10.04
EY9.13%
EPS(NY)12.54
Fwd EY11.4%
FCF(TTM)15.18
FCFY13.8%
OCF(TTM)15.83
OCFY14.39%
SpS25.3
BVpS60.22
TBVpS53.45
PEG (NY)0.78
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 1.03%
ROE 15.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 37.12%
GM N/A
FCFM 60%
ROA(3y)0.91%
ROA(5y)0.81%
ROE(3y)12.92%
ROE(5y)11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y9.26%
PM growth 5Y4.48%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 3.65
Debt/FCF 14.48
Debt/EBITDA N/A
Cap/Depr 37.23%
Cap/Sales 2.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 161.65%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)23.53%
Cap/Depr(5y)26.39%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.4%
EPS 3Y21.26%
EPS 5Y15.63%
EPS Q2Q%20.38%
EPS Next Y13.97%
EPS Next 2Y14.24%
EPS Next 3Y14.4%
EPS Next 5Y4.12%
Revenue 1Y (TTM)11.07%
Revenue growth 3Y7.51%
Revenue growth 5Y5.95%
Sales Q2Q%36.15%
Revenue Next Year36.67%
Revenue Next 2Y20.09%
Revenue Next 3Y14.96%
Revenue Next 5Y3.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.69%
FCF growth 3Y64.09%
FCF growth 5YN/A
OCF growth 1Y-1.11%
OCF growth 3Y58.57%
OCF growth 5YN/A